Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.41
BATS BZX Real-Time Price
As of 11:52am ET
 +0.16 / +3.05%
Today’s Change
2.80
Today|||52-Week Range
7.80
+7.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues4.2M5.8M6.8M9.3M
 
 
 
 
 
Cost of Goods Sold3.5M1.5M1.8M5.7M
 
 
 
 
 
Depreciation And Amortization148.0K165.0K261.0K259.0K
 
 
 
 
 
 
Operating ExpensesGross Income532.0K4.1M4.8M3.3M
 
 
 
 
 
General Expenses31.4M29.6M28.2M27.0M
 
 
 
 
 
Research And Development11.2M8.0M7.6M7.0M
 
 
 
 
 
Total Operating Expenses35.0M31.2M30.2M32.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-30.8M-25.5M-23.4M-23.6M
 
 
 
 
 
Extraordinary Charge0.000.00-2.0M-2.7M
 
 
 
Interest Expense On Debt----15.7M18.5M
 
 
 
Other Expenses100.0K-12.3M6.0K7.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-30.7M-37.8M-40.9M-44.6M
 
 
 
 
 
Income Taxes-22.0K-23.0K-20.0K-20.0K
 
 
 
 
 
Net Income-30.7M-37.8M-41.0M-44.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS105.2M105.2M105.6M105.8M
 
 
 
 
 
Shares To Calculate EPS Diluted105.2M105.2M105.6M105.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.29-$0.36-$0.39-$0.42
 
 
 
 
 
EPS Diluted-$0.29-$0.36-$0.39-$0.42